Acute Kidney Injury After Cardiac Surgery Based on KDIGO Criteria
NCT ID: NCT00777465
Last Updated: 2014-05-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2804 participants
OBSERVATIONAL
2003-01-31
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acute Kidney Injury After Cardiac Surgery
NCT05079724
Acute Kidney Injury After Cardiac Surgery
NCT03396770
Predicting Acute Kidney Injury After Coronary Artery Bypass Graft
NCT02081261
Biomarkers of Acute Kidney Injury in Cardiac Surgery
NCT03830450
AKIN Criteria: Acute Kidney Injury After On-Pump Coronary Artery Bypass Graft (CABG)
NCT00780845
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
KDIGO 0
Patients with no acute kidney injury after cardiac surgery
No interventions assigned to this group
KDIGO 1
Patients with acute kidney injury KDIGO stage 1 after cardiac surgery (Increase in SCr by ≥ 0.3 mg/dL (≥ 26.5 lmol/L) or 1.5 to 1.9 times baseline)
No interventions assigned to this group
KDIGO 2
Patients with acute kidney injury KDIGO stage 2 after cardiac surgery (2.0 to 2.9 times baseline SCr)
No interventions assigned to this group
KDIGO 3
Patients with acute kidney injury KDIGO stage 3 after cardiac surgery (3.0 times baseline or more; or increase in SCr to ≥ 4.0 mg/dL; or initiation of renal replacement therapy)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital de Base
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mauricio de Nassau Machado
Cardiologist in-chief - Coronary Care Unit
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lilia N Maia, PhD
Role: STUDY_DIRECTOR
São José do Rio Preto Medical School
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital de Base
São José do Rio Preto, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CAAE-3436.0.000.140-08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.